It's all about delays due to lack of enrollment in clinical trials. A 2013 study from the same Tufts thinktank as the recent cost report says that 37% of clinical trial sites under-enroll patients and 10% don't get a single patient! Here is a market ripe for disruption: some startup needs to build the uber of clinical trial enrollment. [1]http://csdd.tufts.edu/files/uploads/02_-_jan_15,_2013_-_recr...